This study investigates sporadic pancreatic cancer in individuals at high risk. The purpose of this study is to evaluate a screening program for early detection.
The study focuses on using contrast-enhanced CT scans and blood tests. It evaluates how these methods can help detect pancreatic cancer earlier.
- Who can participate: Individuals aged 50 to 85 years with new-onset diabetes and an ENDPAC score of 3 or higher are eligible, provided they consent and meet other health criteria.
- Study details: Participants will undergo contrast-enhanced CT scans and blood tests to improve image clarity. A placebo is not used in this study.